SCHEMBL1144569

SCHEMBL1144569

C1=CCOC(OC2C=CC=CO2)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4211200 0.72
SCHEMBL3068643 0.67
SCHEMBL4461195 0.63
Water SCHEMBL9550563 0.62
SCHEMBL10447249 0.62 HRH1 (0.33)
SCHEMBL1144567 0.62
SCHEMBL632175 0.61
SCHEMBL8528128 0.61
SCHEMBL15809105 0.61
SCHEMBL11046821 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850262-B1 SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS BRACCO SPA (IT) 2001-05-23 EP claimed
EP-1099698-A1 Macrocyclic oxalactones ( dioxacycloalkan-ones ) and their use as perfumes PFW AROMA CHEMICALS B.V. (NL) 2001-05-16 EP claimed
EP-1099699-A1 Macrocyclic oxalactones ( dioxacycloalkan-ones ) and their use as perfumes PFW AROMA CHEMICALS B.V. (NL) 2001-05-16 EP claimed
US-5994495-A Selectively functionalizable desdendrimers DIBRA S.P.A. (IT) 1999-11-30 US claimed
EP-0850262-A1 SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS BRACCO S.p.A. (IT) 1998-07-01 EP claimed
WO-1997046553-A1 THROMBIN INHIBITORS NOVARTIS AG (CH) 1997-12-11 WO claimed
WO-1997010281-A1 SELECTIVELY FUNCTIONALIZABLE DESDENDRIMERS BRACCO S.P.A. (IT) 1997-03-20 WO claimed
US-5457247-A Process for preparing (s)- and (r) -but-3-en-2-ol and the derivatives thereof from l-or d-lactic acid esters BOEHRINGER INGELHEIM KG (DE) 1995-10-10 US claimed
US-4603213-A Total synthesis of 1RS,4SR,5RS-4-(4,8-dimethyl-5-hydroxy-7-nonen-1-yl)-4-methyl-3,8-dioxabicyclo[3.2.1]octane-1-acetic acid ORTHO PHARMACEUTICAL CORPORATION (US) 1986-07-29 US claimed
JP-2243647-A None JP disclosed
CN-109762034-B Preparation method of novel terephthalaldehyde D-glucosamine Schiff base 福建医科大学 2022-04-29 CN disclosed
US-10479750-B2 Method of producing dialdehyde compound KURARAY CO., LTD. (JP) 2019-11-19 US disclosed
US-20190023636-A1 METHOD OF PRODUCING DIALDEHYDE COMPOUND KURARAY CO., LTD. (JP) 2019-01-24 US disclosed
EP-3424897-A1 METHOD OF PRODUCING DIALDEHYDE COMPOUND Kuraray Co., Ltd. (JP) 2019-01-09 EP disclosed
US-3979414-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-09-07 US disclosed
US-3965115-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-22 US disclosed
US-3963753-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-15 US disclosed
US-3963752-A Disubstituted xanthone carboxylic acid compounds SYNTEX (U.S.A.) INC. (US) 1976-06-15 US disclosed
US-3944576-A Novel steroids of the oestrane series substituted in 7-position AKZONA INCORPORATED (US) 1976-03-16 US disclosed
US-3932467-A Process for the production of 2β-formyl 3α-protected hydroxy-5-oxocyclopentane-1α-heptanoic acids and esters corresponding G. D. SEARLE & CO. (US) 1976-01-13 US disclosed